From advanced pediatric medical and surgical care to in-house research and collaborative clinical investigation with national pediatric leaders, the scientists, providers and care teams at Penn State Children’s Hospital continue to break down barriers to inform treatment and foster excellent outcomes for children and families throughout Pennsylvania and the surrounding region.
New Era of Radiosurgery Launches at Penn State Health Milton S. Hershey Medical Center: Installation of Gamma Knife Icon
As technologies and techniques have advanced in recent years, Gamma Knife radiosurgery has become a vital tool for enhancing outcomes among patients with brain tumors and other complex neurological disorders. Penn State Health Milton S. Hershey Medical Center recently reaffirmed its long-standing commitment to provide the most advanced care in the region by upgrading to the latest iteration of the Gamma Knife radiosurgery system: Leksell Gamma Knife®Icon™.
ESTABLISHED IN 2000, Penn State Cancer Institute, recognized as an American College of Surgeons Commission on Cancer-accredited facility, has evolved into a premier academic oncology center that encompasses clinical care, research, education and outreach. Since 2009, the 178,000-square-foot facility on the Milton S. Hershey Medical Center campus has served as the hub for nearly 160 clinicians, researchers and faculty members based in Hershey and University Park, State College in Centre County. The Cancer Institute care teams see nearly 2,000 individual cases annually.
Pediatric Oncology Experimental Therapeutics at Penn State Children’s Hospital: Bringing Hope to Young Cancer Patients and Their Families
Cooperation, innovation and a passion for saving young lives are the driving forces behind the Pediatric Oncology Experimental Therapeutics Program at Penn State Children’s Hospital.
Childhood cancer survivors living with chronic conditions as adults may experience a kind of accelerated aging due to the late effects of cancer treatment. However, survivors with no chronic conditions enjoy a quality of life similar to that of individuals with no history of cancer, according to a recent study.
Melanoma patients frequently lack the knowledge or confidence to perform regular, effective skin self-exams (SSEs), according to recent research.
A newer class of medications that enables the immune system to identify and attack diseased cells is transforming the way clinicians fight advanced melanoma. At the head of that charge is the drug pembrolizumab.
The synergies created by the joining of Lancaster General Health and the University of Pennsylvania Health System (Penn Medicine) enable providers throughout the system to work in an environment of close collaboration that benefits patients and physicians alike.
Advances in cardiothoracic surgery, neuro-oncology and minimally invasive general surgery have allowed physicians at Penn State Milton S. Hershey Medical Center to redefine surgical care for patients throughout the region.
Incorporating innovative initiatives and leveraging a vast physician network, Penn State Hershey Medical Center and Health System is advancing care throughout the region with research-based medicine, while also educating the next generation of providers.
- 1 of 2
- next ›